The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November
Source : arabianbusiness.com
Read more…India’s Biocon eyes a pie of 0 billion market as patents for blockbuster weight loss drugs start to expire
